Neurocrine Biosciences Inc. (NASDAQ: NBIX) announced it has entered into a definitive agreement to acquire Soleno Therapeutics Inc. (NASDAQ: SLNO) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Mergers and Acquisitions

Neurocrine Bio. (NBIX) PT Raised to $200 at CanaccordApril 6, 2026 2:41 PM